Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2004-002015-86Phase 3Completed
Phase 3, randomised trial of calcipotriol and betamethasone dipropionate in psoriasis (4 arms), sponsored by LEO Pharma. Primary endpoint: Controlled disease at end of treatment. Started Oct 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2004-002015-86.